Turn Therapeutics Inc. Common Stock Cash Flow Quality Index

Latest as of December 2025: -4.21x

Turn Therapeutics Inc. Common Stock cash flow quality index. Turn Therapeutics Inc. Common Stock (TTRX) has a Cash Flow Quality Index of -4.21x as of December 2025. Operating cash flow of $-1.18 Million is below net income of $279.07K, suggesting accrual-heavy earnings not yet converted to cash. See Turn Therapeutics Inc. Common Stock (TTRX) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-4.21x
Operating CF / Net Income

Operating Cash Flow

$-1.18 Million
USD

Net Income

$279.07K
USD

Data as of

Dec 2025
Most recent filing

Turn Therapeutics Inc. Common Stock Cash Flow Quality Index by Year (None–None)

Turn Therapeutics Inc. Common Stock cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Turn Therapeutics Inc. Common Stock. For the full cash flow conversion analysis, see Turn Therapeutics Inc. Common Stock (TTRX) cash conversion ratio.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.